Human recombinant interleukin-2 is mitogenic to human lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Interleukin-2 (IL-2) is a critical cytokine for T cell growth and function.
• Understanding the precise role of IL-2 in lymphocyte activation is essential for immunology research.

Purpose of the Study:

• To investigate the mitogenic potential of purified recombinant human interleukin-2 (hrIL-2) on human lymphocytes.
• To define the specificity of hrIL-2-induced T cell responses and identify factors influencing its activity.

Main Methods:

• Lymphocyte proliferation assays using purified hrIL-2.
• Blocking experiments with anti-Tac monoclonal antibody to inhibit the IL-2 receptor.
• Depletion and reconstitution experiments with mononuclear leukocytes and interleukin-1 (IL-1).
• Co-stimulation studies with hrIL-2 and OKT3 monoclonal antibody.

Main Results:

• Purified hrIL-2 demonstrated potent mitogenic activity for lymphocytes from healthy donors.
• The mitogenic effect of hrIL-2 was specifically blocked by the anti-Tac antibody, confirming IL-2 receptor involvement.
• Lymphocyte reactivity to hrIL-2 was reduced by removing adherent cells but restored with IL-1.
• Combined treatment with hrIL-2 and OKT3 antibody enhanced lymphocyte proliferative responses.

Conclusions:

• Recombinant human interleukin-2 (hrIL-2) acts as a potent mitogen for human lymphocytes.
• hrIL-2, similar to antigens and phytomitogens, can function as an initial signal for T cell proliferation.
• Interleukin-1 (IL-1) plays a role in supporting hrIL-2-mediated lymphocyte responses.